In a recent study in Caucasian patients (63), anti-PLA2R antibodies were positive in 75% of patients with idiopathic MN and in 9 out of 32 (28%, in seven patients with cancer) with secondary MN. The gene discussed is PLA2R1; the disease is cancer.